If you wish to report an adverse event or product complaint, please call 1-800-LILLYRX (1-800-545-5979)
Amyvid ® (florbetapir F18 injection)
500-1900 MBq/mL
This information is provided in response to your request. Resources may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above, if applicable.
Have the original IDEAS study results been published?
The original IDEAS study results have been published; links to the publications are provided below.
Original IDEAS Study Publications
The results for the original Imaging Dementia - Evidence for Amyloid Scanning (IDEAS) study have been published and are available at
- Rabinovici GD, Gatsonis C, Apgar C, et al. Association of amyloid positron emission tomography with subsequent change in clinical management among Medicare beneficiaries with mild cognitive impairment or dementia. JAMA. 2019;321(13):1286-1294. https://doi.org/10.1001/jama.2019.2000, and
- Rabinovici GD, Carillo MC, Apgar C, et al. Amyloid positron emission tomography and subsequent health care use among Medicare beneficiaries with mild cognitive impairment or dementia. JAMA Neurol. 2023;80(11):1166-1173. https://doi.org/10.1001/jamaneurol.2023.3490.
Additional information about the study may be available at: https://www.ideas-study.org/Original-Study
Enclosed Prescribing Information
Date of Last Review: June 07, 2024